IL17F and rheumatoid arthritis: In addition, IL-17F correlates with disease severity by DAS28 and CDAI, Losartan was able to sensitize patients' cells in remission/mild/moderate RA condition reducing the levels of this cytokine, but no effects were seen in severe score.